中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2014年
11期
82-84
,共3页
恶性黑色素瘤%化疗%治疗现状
噁性黑色素瘤%化療%治療現狀
악성흑색소류%화료%치료현상
Malignant melanoma%Chemotherapy%Treatment status quo
恶性黑色素瘤是恶性程度高的肿瘤，其预后差，尤其是转移性的恶性黑色素瘤仍较难治疗。达卡巴嗪已不再显示其优越性。随着近年来对恶性黑色素瘤的深入研究，新的化疗药物、免疫、靶向药物治疗显示出了好的应用前景。
噁性黑色素瘤是噁性程度高的腫瘤，其預後差，尤其是轉移性的噁性黑色素瘤仍較難治療。達卡巴嗪已不再顯示其優越性。隨著近年來對噁性黑色素瘤的深入研究，新的化療藥物、免疫、靶嚮藥物治療顯示齣瞭好的應用前景。
악성흑색소류시악성정도고적종류，기예후차，우기시전이성적악성흑색소류잉교난치료。체잡파진이불재현시기우월성。수착근년래대악성흑색소류적심입연구，신적화료약물、면역、파향약물치료현시출료호적응용전경。
Melanoma melanoma is a kind of high degree of malignancy tumor,and has poor prognosis. Specifically metastatic melanoma remains a difficult disease to treat. Dacarbazine no longer shows its superiority. In recent years,with the further study of malignant melanoma,new chemotherapy drugs,targeted therapy and immune therapy show good prospect.
